Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Debt Ratio (2021 - 2025)

Verrica Pharmaceuticals has reported Debt Ratio over the past 4 years, most recently at 0.3 for Q3 2025.

  • Quarterly results put Debt Ratio at 0.3 for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was 0.3 (changed N/A YoY), and the annual figure for FY2024 was 0.24, changed.
  • Debt Ratio for Q3 2025 was 0.3 at Verrica Pharmaceuticals, down from 0.32 in the prior quarter.
  • Over the last five years, Debt Ratio for VRCA hit a ceiling of 0.67 in Q2 2022 and a floor of 0.24 in Q4 2024.
  • Median Debt Ratio over the past 4 years was 0.4 (2021), compared with a mean of 0.42.
  • Peak annual rise in Debt Ratio hit 61.01% in 2022, while the deepest fall reached 55.88% in 2022.
  • Verrica Pharmaceuticals' Debt Ratio stood at 0.52 in 2021, then increased by 28.13% to 0.67 in 2022, then tumbled by 64.15% to 0.24 in 2024, then grew by 27.46% to 0.3 in 2025.
  • The last three reported values for Debt Ratio were 0.3 (Q3 2025), 0.32 (Q2 2025), and 0.3 (Q1 2025) per Business Quant data.